A Novel Nonpeptide CGRP Receptor Antagonist, ‘Compound 1’ (WO98/11128) Is a High Affinity Competitive Antagonist at the CGRP1 Receptor in Human Coronary Arteries

The Scientific World Journal - Egypt
doi 10.1100/tsw.2001.416
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

SB 209670, a Rationally Designed Potent Nonpeptide Endothelin Receptor Antagonist.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1994English

Anti-Inflammatory Properties of a Novel Peptide Interleukin 1 Receptor Antagonist

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2014English

Interleukin-1 Receptor Antagonist Gene Polymorphism and Coronary Artery Disease

Circulation
Cardiovascular MedicinePhysiologyCardiology
1999English

A Novel Mutation in the Interleukin-1 Receptor Antagonist Associated With Intrauterine Disease Onset

Clinical Immunology
AllergyImmunology
2012English

Effects of WIN 64338, a Nonpeptide Bradykinin B2 Receptor Antagonist, on Guinea-Pig Trachea

British Journal of Pharmacology
Pharmacology
1995English

Interleukin-1, Interleukin-1 Receptor, and Interleukin-1 Receptor Antagonist

Proceedings of the Nutrition Society
MedicineNutritionDietetics
1994English

Effects of High Affinity Leptin Antagonist on Prolactin Receptor Deficient Male Mouse

PLoS ONE
Multidisciplinary
2014English

A Novel Glucagon Receptor Antagonist Inhibits Glucagon-Mediated Biological Effects

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2004English

Interleukin-1 Receptor Antagonist Genotype Is Associated With Coronary Atherosclerosis in Patients With Type 2 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy